Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. - Wikidata - awgldk - TriplyDB

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

http://www.wikidata.org/entity/Q53085005

about

Increasing incidence of colon cancer in patients <50 years old: a new entity?Clinical Genetic Testing in Gastroenterology Implications of mismatch repair-deficient status on management of early stage colorectal cancer Mouse models for the discovery of colorectal cancer driver genes Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome Cancer predisposition genes: molecular mechanisms and clinical impact on personalized cancer care: examples of Lynch and HBOC syndromes Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan Deficient mismatch repair: Read all about it (Review)How do we approach the goal of identifying everybody with Lynch syndrome?PMS2 monoallelic mutation carriers: the known unknown Opportunities for immunotherapy in microsatellite instable colorectal cancer New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care Practical issues related to uterine pathology: staging, frozen section, artifacts, and Lynch syndrome Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?Risk of metachronous colorectal cancer following colectomy in Lynch syndrome: a systematic review and meta-analysis.The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment.omicsNPC: Applying the Non-Parametric Combination Methodology to the Integrative Analysis of Heterogeneous Omics Data.Genetic testing strategies in newly diagnosed endometrial cancer patients aimed at reducing morbidity or mortality from lynch syndrome in the index case or her relatives Universal molecular screening does not effectively detect Lynch syndrome in clinical practice Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2.Familial cancer among consecutive uterine cancer patients in Sweden.Case Report of Menopausal Woman Diagnosed with Endometrial Cancer after Colon Cancer with Germline Mutation in MSH6 in Korea Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers.Simplified microsatellite instability detection protocol provides equivalent sensitivity to robust detection strategies in Lynch syndrome patients.Epidemiology matters: peering inside the "black box" in economic evaluations of genetic testing Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer.Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables.Somatic mutation patterns and compound response in cancers.The mutational spectrum of Lynch syndrome in cyprus.The genetic basis of Lynch syndrome and its implications for clinical practice and risk management.Current status of long non-coding RNAs in human cancer with specific focus on colorectal cancer.Familial colon cancer syndromes: an update of a rapidly evolving field Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer.Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method New facial papules in a 66-year-old woman with bladder cancer Hereditary nonpolyposis colorectal cancer (HNPCC)/Lynch syndrome.Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer.Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database.Cervical neuroendocrine tumor in a young female with Lynch Syndrome.

P2860

Q26747528-D1B8182D-399D-48F7-95FE-D4CEEE595D5D Q26749157-D78D3424-7B38-46FF-A8CC-A591FDFF6A4B Q26772272-6422EA9D-FE67-407C-BD91-C3447A64A167 Q26774627-8EE559E6-8770-4241-8715-891CBABC444F Q26775022-6EB7153B-6E4C-4E66-B57D-68D4CFA1B018 Q26776258-2E6BA9D5-2178-4840-9210-90191CA1FE45 Q26779546-DD55BBCA-896D-45F6-873A-31B0B16AC7F6 Q26796491-3004E2D6-F9C9-4C68-A33C-32E81A1FCBB5 Q26865836-461B582B-391E-4C4B-91EA-B60143580649 Q27024662-4465DDCA-7E3B-43DC-83D7-6FF44BF9FD93 Q28066110-8B3663AA-C492-4DE5-A787-A0DE5C731669 Q28078792-495045CE-E60D-4F1D-A449-120520831771 Q28080146-1173243E-6B34-47F2-B5BC-346CA527A1DC Q28085485-93C2DED5-BEBA-480A-A91E-436EBF4A248A Q30234819-061CADC0-D1C0-448D-81FF-3CE5CB3954DA Q30234889-F0873BC5-64A1-496D-82A8-34B4F2EEB1F0 Q30827406-639A5A15-7F85-4AF2-B891-6938A5F823FE Q31139897-6F659F65-A3C1-46D7-8832-459EEFABD54C Q33605565-3F1EBC1A-83F9-4B9A-BFC6-3763B290513C Q33640008-C2DFD6F1-C624-488B-B7AE-B442087A73CE Q33646157-A1EF7E45-8ABD-48A1-A70B-E421A46803D9 Q33689400-B3B4BE76-CB43-47A9-96A7-5E99E201B2AB Q33699887-4726007C-DA76-4E95-AD69-0C3CA4E0CD46 Q33728916-07BBFFD1-E1CE-46BE-BA9C-A6BF99D1282B Q33764223-EA872E15-1E54-48AC-919C-968A6DFA8F34 Q33874719-681290B9-B917-47AD-ADB5-C3F08531B46A Q34023517-587DFF86-B977-40AE-AD6D-F9D937577C50 Q34049334-566765B9-106A-4D6F-870A-19D55DE04835 Q34062115-B65BFB8D-A350-4914-AFF8-9489B80EAF75 Q34081267-59118756-AAF0-40EE-9E1E-967135EF6779 Q34158506-6D1C641A-D3D6-4A8F-8337-184EA8CD9658 Q34292368-D92F5CA8-0824-4C4F-BDC7-7102EFFE59F4 Q34356721-D5C515A8-5B22-4701-8A3F-D681523F2381 Q34481263-BB7F4ADF-0486-4A25-AFC3-BD79AED99D3B Q34514962-C9CCA6A4-E758-4971-8F4D-536ED9DD5E37 Q34620160-722940B9-F8DE-4122-B933-32EE6481B85F Q34648373-F3CD9F49-8788-4444-9057-C51D37DED18A Q34785026-AC3653AB-B8F0-4413-B696-A8E50C8683F0 Q34961153-CF94081B-DC73-4BC1-A19F-25A50733DA54 Q35019094-878DB8B5-36C2-4A1A-810B-0AC26835E737

P2860

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

http://www.wikidata.org/entity/Q53085005

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Cancer risks associated with g ...... MSH6 genes in Lynch syndrome.

@en

Cancer risks associated with g ...... MSH6 genes in Lynch syndrome.

@nl

type

label

Cancer risks associated with g ...... MSH6 genes in Lynch syndrome.

@en

Cancer risks associated with g ...... MSH6 genes in Lynch syndrome.

@nl

prefLabel

Cancer risks associated with g ...... MSH6 genes in Lynch syndrome.

@en

Cancer risks associated with g ...... MSH6 genes in Lynch syndrome.

@nl

P1433

Q53085005-8E91A299-9E69-4CD9-9863-3737E9407286

P1476

Q53085005-92189B7F-D850-4930-BD60-6729290A644C

P2093

Q53085005-00DEE1B6-FBF9-4ECF-B1C0-0FCB212C8F41

Q53085005-0EAA8800-55AF-47C8-8303-6066E7A3AF2A

Q53085005-13B1E691-4487-4981-90A0-F3CE66FA20B3

Q53085005-20101101-2192-445E-AA02-15B9AFC414A0

Q53085005-20A7DBA8-442E-4B71-8685-C6697B9C2B98

Q53085005-228A3A1D-DCDA-4153-92E7-BC4A06124CD4

Q53085005-2BEF7408-8A77-4514-AE83-D352A2CD8FA0

Q53085005-44407B7F-26DE-4830-BE35-FCAF7FCFEFAD

Q53085005-47508ED0-B0A6-4F7F-A3AA-3C881C409A19

Q53085005-4E3B674D-5DEA-4463-B542-76A7E0E13D3E

P304

Q53085005-1F7FA412-1CBB-4115-9571-ADE50A9D009D

P31

Q53085005-D45D4E83-87F6-4AA1-872C-3C3A947C1FAD

P3181

Q53085005-34d49fb0-445f-8311-3d76-4cc57c5c2791

P356

Q53085005-FFBD0916-4219-4568-9E52-5CA701E1BE63

P407

Q53085005-61E50B7B-06DE-4A05-A67F-8C51B41DDB32

P433

Q53085005-01DB08EC-113C-4E1A-A5B9-2323E864DF52

P478

Q53085005-1DCA92BD-F198-44F9-AE31-70B02B1F31F9

P577

Q53085005-D9C0C770-71CB-4682-A777-305553F94BF4

P5875

Q53085005-B04FD7A6-1BB0-47DB-8A8C-992FAB304E75

P698

Q53085005-179D9437-2BD4-429A-8AAE-15A98C5AF335

P3181

P356

P1433

Journal of the American Medical Association

P1476

Cancer risks associated with g ...... MSH6 genes in Lynch syndrome.

@en

P2093

Bernard Bonaïti

http://www.w3.org/2001/XMLSchema#string

Bruno Buecher

http://www.w3.org/2001/XMLSchema#string

Catherine Bonaïti-Pellié

http://www.w3.org/2001/XMLSchema#string

Catherine Noguès

http://www.w3.org/2001/XMLSchema#string

Christine Lasset

http://www.w3.org/2001/XMLSchema#string

Chrystelle Colas

http://www.w3.org/2001/XMLSchema#string

Dominique Leroux

http://www.w3.org/2001/XMLSchema#string

Florence Polycarpe-Osaer

http://www.w3.org/2001/XMLSchema#string

Françoise Desseigne

http://www.w3.org/2001/XMLSchema#string

French Cancer Genetics Network

http://www.w3.org/2001/XMLSchema#string

P304

2304-2310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2017311

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/JAMA.2011.743

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

305

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51192942

http://www.w3.org/2001/XMLSchema#string

P698

21642682

http://www.w3.org/2001/XMLSchema#string